Capital One upgraded at BTIG on Discover Financial deal prospects
Capital One Financial (NYSE:COF) stock was rising after BTIG upgraded the credit card and auto lender on Discover Financial ...
CrowdStrike ticks up on back of BTIG upgrade
CrowdStrike (NASDAQ:CRWD) shares rose 2% in premarket trading on Tuesday after BTIG upgraded the cybersecurity firm. Analyst ...
Ovid Therapeutics price target lowered to $4 from $5 at BTIG
BTIG analyst Thomas Shrader lowered the firm’s price target on Ovid Therapeutics (OVID) to $4 from $5 and keeps a Buy rating on the shares ...
Darden price target raised to $210 from $205 at BTIG
BTIG raised the firm’s price target on Darden (DRI) to $210 from $205 and keeps a Buy rating on the shares after its Q3 results. Despite a 100 ...
Orchestra BioMed (NASDAQ:OBIO) Research Coverage Started at BTIG Research
BTIG Research initiated coverage on shares of Orchestra BioMed (NASDAQ:OBIO – Free Report) in a report released on Thursday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $12.
The S&P 500's mini pullback has to stay above this level for bulls to have hope
The S&P 500's pullback on what is known on Wall Street as "turnaround Tuesday," needs to stay above the 5,580 level for bulls to retain hope that the big rally over the previous two days was more than ...
BTIG Sticks to Its Buy Rating for Exact Sciences (EXAS)
Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.
BTIG Keeps Their Buy Rating on Guardant Health (GH)
Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.
MarketWatch15d
S&P 500 oversold and near seasonal support, says BTIG's Krinsky
But Jonathan Krinsky, technical strategist at BTIG, has some potentially good news for equity bulls. Short-term technical signals suggest the S&P 500 and Nasdaq 100 are oversold, he says ...